Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $1B+, returning 12,699.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,699.4% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,992.96% |
Abivax SA American Depositary Shares (ABVX) | 1,059.12% |
Mobilicom Limited Warrants (MOBBW) | 612.21% |
ThredUp (TDUP) | 554.86% |
TMC the metals (TMC) | 550% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 511.41% |
Nukkleus (NUKKW) | 507.97% |
Oklo (OKLO) | 499.91% |
Asset Entities Inc Class B Common Stock (ASST) | 420% |
Centrus Energy (LEU) | 408.72% |
Opendoor Technologies (OPEN) | 399.08% |
IREN (IREN) | 389.43% |
Circle Internet (CRCL) | 370.26% |
Forward Industries (FORD) | 360.74% |
Nebius (NBIS) | 354.96% |
MP Materials (MP) | 351.1% |
Amprius Technologies (AMPX) | 342.36% |
Mercurity Fintech Holding Inc ADR (MFH) | 340.93% |
China Yuchai International (CYD) | 322.66% |
Nektar Therapeutics (NKTR) | 321.8% |
Americas Silver (USAS) | 314.48% |
Bloom Energy (BE) | 301.11% |
Ondas (ONDS) | 296.4% |
